Anti-Imperialism and the Global Left: New Appraisals

Cervical cerclage

Reply

The Sociology of Conflict. I

van Gaalen, J.F.; Tebbens, S.F., and Barton, C.C., 2016. Longshore sediment transport directions and rates from northern Maine to Tampa Bay, Florida: Literature compilation and interpretation. This paper examines site-specific and regional longshore sediment transport directions and rates along the U.S. seaward coast from the northern Maine border to the mouth of Tampa Bay, Florida. From previous studies, it is known that along the coast, there are nodal zones, i.e. locations of divergence or convergence in longshore current, as well as variations in current direction and sediment transport rate. Available published field-based studies of sediment transport directions and rates were compiled to create a map of the direction and rate of longshore transport. A detailed compilation of local and regional published studies is provided in tables and in a sequence of eight regional maps. Compiled studies of longshore transport reveal a dominant southward direction. On the regional scale, 12 nodal zones ...

BackgroundFacet joints’ (FJ) ankylosis was reported to occur frequently in patients with ankylosing spondylitis (AS). However, a detailed FJ evaluation was not reported in patients over the spectrum of axial...

Background/Aims Acute anterior uveitis (‘uveitis’) is a common extra musculoskeletal manifestation of axial spondyloarthritis (axSpA). Interleukin (IL)-17 has been implicated in uveitis pathogenesis; however, inhibition of IL-17A alone may not be optimal for uveitis management. We report the incidence of uveitis following IL-17A and IL17F inhibition with bimekizumab (BKZ) in patients with axSpA. Methods Data were pooled for patients randomised to placebo (PBO) or BKZ 160mg every 4 weeks (Q4W) in the double-blind treatment period (DBTP) of the phase (ph)3 studies BE MOBILE 1 (NCT03928704; non-radiographic axSpA) and 2 (NCT03928743; radiographic axSpA [i.e. ankylosing spondylitis]). Data were also pooled for all patients treated with BKZ in BE MOBILE 1, BE MOBILE 2, BE MOVING (NCT04436640; open-label extension [OLE] of BE MOBILE 1 and 2), the ph2b study BE AGILE (NCT02963506; r-axSpA) and its OLE BE AGILE 2 (NCT03355573; data cut-off 4 July 2022). Uveitis events were identified using the preferred terms “autoimmune uveitis,” “iridocyclitis,” “iritis” and “uveitis,” and are reported as exposure adjusted incidence rates (EAIRs) per 100 patient-years (PY) for all patients who received ≥1 BKZ dose. Results Baseline characteristics of the axSpA study populations are shown in the Table. In the DBTP of BE MOBILE 1 and 2, uveitis events occurred in 11/237 (4.6%; EAIR/100 PY [95% CI]: 15.4 [7.7, 27.5]) and 2/349 (0.6%; 1.8 [0.2, 6.7]) patients randomised to PBO and BKZ (percentage difference [95% CI]: 4.1 [1.7, 7.6]), respectively. In 45 PBO-randomised (19.0%) and 52 BKZ-randomised (14.9%) patients with history of uveitis, uveitis occurred in 20.0% (EAIR/100 PY [95% CI]: 70.4 [32.2, 133.7]) and 1.9% (6.2 [0.2, 34.8]) of patients, respectively. In the ph2b/3 pool (N = 848) total BKZ exposure was 2,034.4 PY and 130 (15.3%) patients had history of uveitis. Uveitis occurred in 25 (2.9%; EAIR/100 PY [95% CI]: 1.2 [0.8, 1.8]) and 14 (10.8%; 4.6 [2.5, 7.7]) patients overall and with history of uveitis, respectively. All uveitis events were mild/moderate; one led to discontinuation. Conclusion Incidence of uveitis was lower to Week 16 in patients with axSpA randomised to BKZ 160mg Q4W versus PBO and remained low at 1.2/100 PY in the largest ph2b/3 pool. Disclosure M. Rudwaleit: Consultancies; AbbVie, Eli Lilly, Novartis and UCB Pharma. Member of speakers’ bureau; AbbVie, Boehringer Ingelheim, Chugai, Eli Lilly, Janssen, Novartis, Pfizer and UCB Pharma. M.A. Brown: Consultancies; Clementia, Grey Wolf Therapeutics, Incyte, Ipsen, Pfizer, Regeneron and Xinthera. Member of speakers’ bureau; Novartis and Pfizer. Grants/research support; UCB Pharma. F. van Gaalen: Grants/research support; Jacobus Stichting, Novartis, Stichting ASAS, Stichting Vrienden van Sole Mio and UCB Pharma. Other; fees from Novartis; personal fees from AbbVie, BMS, Eli Lilly and MSD. N. Haroon: Consultancies; AbbVie, Eli Lilly, Janssen, Novartis and UCB Pharma. L.S. Gensler: Consultancies; AbbVie, Acelyrin, Eli Lilly, Fresenius Kabi, Janssen, Novartis, Pfizer and UCB Pharma. Grants/research support; Novartis and UCB Pharma paid to institution. C. Fleurinck: Other; Employee of UCB Pharma. A. Marten: Other; Employee of UCB Pharma. U. Massow: Other; Employee of UCB Pharma. N. de Peyrecave: Other; Employee of UCB Pharma. T. Vaux: Other; Employee of UCB Pharma. K. White: Shareholder/stock ownership; UCB Pharma. Other; Employee of UCB Pharma. A. Deodhar: Consultancies; AbbVie, BMS, Eli Lilly, Janssen, MoonLake, Novartis, Pfizer and UCB Pharma. Member of speakers’ bureau; Janssen, Novartis and Pfizer. Grants/research support; AbbVie, BMS, Celgene, Eli Lilly, MoonLake, Novartis, Pfizer and UCB Pharma. D. McGonagle: Consultancies; AbbVie, Celgene, Janssen, Merck, Novartis, Pfizer and UCB Pharma. Honoraria; AbbVie, Celgene, Janssen, Merck, Novartis, Pfizer and UCB Pharma. Member of speakers’ bureau; AbbVie, Celgene, Janssen, Merck, Novartis, Pfizer and UCB Pharma. Grants/research support; AbbVie, Celgene, Janssen, Merck and Pfizer. I. van der Horst-Bruinsma: Consultancies; Abbvie, Eli Lilly, MSD, Novartis and UCB Pharma. Other; unrestricted grants received for investigator-initiated studies from AbbVie, MSD, Pfizer and UCB Pharma; fees received for lectures from AbbVie, BMS, MSD and Pfizer.

The Netherlands Universities Foundation for International Cooperation (Nuffic) conducted a study (van Gaalen, Hobbes, Roodenburg, Gielesen, 2014) into institutional policy on internationalization in 2014 in the Netherlands. This study included most Dutch Higher Education Institutions (HEIs). Of these, 27 (59%) had a internationalization central-level plan, eight (17%) were developing such a plan, whilst seven (15%) did not have a separate central- level plan. Only four of the HEIs (9%) in the study did not have a central-level internationalization policy. It can be concluded that the penetration of internationalization in terms of policy is high in the Netherlands. This article is a part of an extensive research project developed by the International Business Centre of Expertise at the HAN University of Applied Sciences and traces the recent institutional developments within the context of its strategic planning and internationalization policies. In particular, this article deals with the “Student Mobility“ dimension of the CIGE model (CIGE, 2013).

Due to the growing trend in higher education accountability, many postsecondary institutions are now measuring student learning outcomes, including ones related to global or intercultural learning (de Wit, 2009; Deardorff & van Gaalen, 2012; Green, 2012; Egron-Polak & Hudson, 2014). However, a closer look is required at those assessment efforts which, although growing in popularity, are not always designed well, executed effectively, or leveraged to maximum effect.

The internationalisation of higher education is a key priority for the Dutch Ministry of Education, Culture and Science. Its aim is that all students in the Netherlands will have obtained international and intercultural competences upon graduation. As it is expected that, even in the near future, not all students will go abroad during their studies, this article discusses how internationalisation at home (IaH) can be stimulated based on the results of a study of 54 Dutch Higher Education institutions (van Gaalen, Hobbes, Roodenburg, & Gielesen, 2014). No less than 91% of Dutch institutions participating in the study have an internationalisation policy at the central level.

Discussion of: van Gaalen, J.F.; Tebbens, S.F., and Barton, C.C., 2016. Longshore Sediment Transport Directions and Rates from Northern Maine to Tampa Bay, Florida: Literature Compilation and Interpretation. <i>Journal of Coastal Research</i>, 32(6), 1277–1301.

FRI0475 ANTI-CD74 antibodies as diagnostic biomarker for early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort study

Lankhorst, K, Takken, T, Zwinkels, M, van Gaalen, L, Velde, St, Backx, F, Verschuren, O, Wittink, H, and de Groot, J. Sports participation, physical activity, and health-related fitness in youth with chronic diseases or physical disabilities: the health in adapted youth sports study. J Strength Cond Res 35(8): 2327-2337, 2021-Youth with chronic diseases or physical disabilities (CDPD) often show reduced fitness and physical activity (PA) levels and participate less in organized sports compared with healthy peers. The purpose of this study was to examine the associations between participation in sports and health-related fitness and PA in youth with CDPD. A total of 163 subjects (mean age 14 years; range 8-19 years) with CDPD were included in this cross-sectional study, with 81 participating in organized sports and 82 not. Subjects were recruited between October 2014 and November 2016. Aerobic and anaerobic fitness, agility, and muscle strength were assessed in the laboratory, whereas PA was monitored in daily life using accelerometry during 1 week. Linear regression analyses were used to assess the associations of sports participation (independent variable) with health-related fitness and PA (dependent variables). Results show that youth with CDPD participating in organized sports 2 times a week performed better on all outcome measures. They reached a higher peak oxygen uptake (difference of 4.9 ml O2·kg-1·min-1, P = 0.001) compared with their peers not participating in sports. Also, anaerobic fitness, agility, muscle strength, and PA were all positively associated with sports participation. Moreover, the association between sports participation and aerobic fitness was mediated by PA for 31% (P = 0.045). In conclusion, participation in sports is associated with both higher levels of PA and health-related fitness in youth with CDPD. Promotion and stimulation of participation in sports seems a good way to promote health-related fitness as well as a healthy active lifestyle in youth with CDPD.

Comprehensive Internationalization at HAN University of Applied Sciences Collaboration and Partnerships

OP0008 DEVELOPMENT AND VALIDATION OF AN ALTERNATIVE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE WHEN PATIENT GLOBAL ASSESSMENT IS UNAVAILABLE

Following the publication of the above paper in the August 2001 issue of Yeast 18(11): 1023–1033, it has come to our attention that there is an error in the spelling of an author's name on p. 1023. ‘Arthur L. Kruckberg’ should read ‘Arthur L. Kruckeberg’. The publishers would like to apologise for any inconvenience or confusion caused.